Excerpts

Within the TCGA-LIHC cohort, the expression of MFSD12 demonstrated highly significant positive correlations with the transcript levels of these immune-checkpoint molecules ( Figure 9B ).

This included twelve biomarkers, including CD28, PD–L1, PD–L2, LAG–3, TIM–3, CD36, IL–1α, GDF–15, PAI–1, HGF, FGF–2, and MMP–1, and notably, a strong trend of association for three others (IL–8, SDF–1α, and EGF).

29.49 ± 6.03, P < 0.001) at M6, the 24-h urinary protein levels showed no significant statistical difference at M6 ( P = 0.379) and M12 ( P = 0.714) ( Tables 2 , 3 ) Both the CTX and RTX groups showed a decreasing trend in proteinuria over the 12-month treatment period, while serum albumin levels exhibited an increasing trend ( Supplementary Figure S1 ).

We identified proteins that were nominally significant in at least two analyses and aligned in direction in three analyses as potential causal biomarkers.

Therefore, the choice of detection method in early-phase trials may be significant, as it can influence the characterization of the enriched patient population and the subsequent interpretation of efficacy signals ( 63 ).

However, RPL14 expression showed a decreasing trend in ARDS samples, though this difference was not statistically significant, likely due to the limited sample size.

These findings were consistently reproduced in independent experimental sets ( Figures 7D–F , SW872 human adipocytes; Figures 7G–I , eWAT), where PRCP upregulation was highly significant ( Figures 7D, G ), UCHL1 expression was robustly increased ( Figures 7E, H ), and BTG2 levels were consistently downregulated across all comparisons ( Figures 7F, I ).

Within STS, they were enriched in the P1 (“immune high”) subgroup and showed a trend toward higher frequencies in patients with better survival.

Although the combination of chemotherapy with benmelstobart plus anlotinib showed a trend towards delayed disease progression (all HRs <1), no superiority was observed against other ICI combination therapies ( Figure 3A ).

Notably, the anti-inflammatory cytokines Il10 and Il13 displayed a clear trend toward increased expression in Treg-expanded animals ( Figures 4E, F , respectively). 4.

Pparγ , which was elevated in diabetic animals, showed a mild trend toward reduction after Treg expansion, again more evident in females ( Figure 4D ).

HM demonstrated a significant trend toward superior efficacy in reducing tissue histamine compared to OM.

It was found that the PLS-DA plot showed a clear separation of the HM sample from the AR sample, with a slight trend of dissociation from the AR group ( Figure 5B ).

An analysis for the CD56 dim NK cell population was performed; patients with a high percentage showed a trend toward lower survival probability (log-rank HR = 2.436), but the difference was not statistically significant (log-rank p = 0.1831; 95% CI: 0.6553-9.055) (not shown).

We observed a positive trend of LDR-induced expression of CD25 on NK cells at 3.5 and 6-month time points, with 10 mGy and 100 mGy reaching statistical significance at 3.5 and 6-month time points, respectively ( Figure 4B ).

In a sensitivity analysis that included all participants analysed in each study, the cumulative number of days of cough, which had shown a significant difference in the per-protocol of MA, no longer differed significantly between the two groups, whereas the cumulative number of days of sore throat, which was not significant in the per-protocol of MA, showed a trend toward reduction in the LC-Plasma group.

The plasma concentrations of CXCL2 confirmed the RNA sequencing (RNAseq) data, while other chemokines, such as CCL20, showed a trend that did not quite reach statistical significance ( Figure 6 ).

A P value < 0.05 was considered statistically significant, and P < 0.01 was considered highly significant.

A retrospective clinical study has shown a U-shaped relationship between the triglyceride-glucose (TyG) index and myocardial injury in patients with HS with a decreasing trend in risk observed at TyG values ≤ 8.897 and pronounced increase in risk at values ≥ 8.966 ( 67 ).

CD4 + T-cell proportions showed an increasing trend in women within the analysis time points whereas proportions were declining in men, resulting in significantly higher CD4 + T-cell proportions in women at T5 ( Figure 2D ).

Phage therapy showed a trend toward improved clinical scores, but this effect did not reach significance.

The results revealed a strong and highly significant positive correlation between ferroptosis and entotic cell death with the involved metabolic pathways, while disulfidptosis showed a significant negative correlation.

Specifically, non-contiguous nodal involvement(COINR Non-contiguous) (HR 20.9; 95% CI 3.92–112; P < 0.001), and the involvement of three or more nodal regions(NOIOR≥3) (HR 11.4; 95% CI 1.37–95.3; P = 0.024) were all highly significant predictors of a shorter PFS ( Table 3 , Figure 3e ).

Collectively, these findings indicate that TREX1, NOX4, and RRM2 may be significant contributors to the progression of prostate cancer; however, their precise roles and potential therapeutic implications warrant further investigation.

The PARP inhibitor ABT-888 (Veliparib) showed a trend toward increased activity, with case reports and early-phase studies suggesting that tumors harboring homologous recombination repair deficiencies, particularly BRCA2 alterations, may be more susceptible; however, evidence in prostate cancer remains limited ( 31 ).